Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.347ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.347ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.347ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.347NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.195ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.195ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.195ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.195NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.321ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.321ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.321ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.321NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.379ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.379ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.379ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.379NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.78ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.78NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.231ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.231ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.231ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.231NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.49ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.49NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.67ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.190ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.190ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.190ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.190NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.120ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.120ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.120NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
AM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used